NEO logo

NeoGenomics (NEO) Free Cash Flow

Annual FCF

-$30.70 M
+$66.18 M+68.31%

December 31, 2023

Summary

Performance

1-Year Change

+68.31%

3-Year Change

-11.11%

5-Year Change

-200.75%

15-Year Change

-806.35%

NEO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.52%
NEO annual free cash flow is higher than 40.52% of companies in Healthcare sector

High & Low

All-time High

$30.48 M
NEO annual free cash flow is currently -200.75% below its historical high of $30.48 million

3-Year Low

-$96.88 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NEO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 18, 2025
NEO next annual earnings announcement is scheduled for Feb 18, 2025

OtherNEOcash flowmetrics:

Annual CFO

-$1.95 M
NEO annual cash flow from operations is -$1.95 million

Annual CFF

$4.55 M
NEO annual cash flow from financing activities is $4.55 million

Annual CFI

$76.71 M
NEO annual cash flow from investing activities is $76.71 million

Annual CAPEX

$28.75 M
NEO annual capital expenditures is $28.75 million

Quarterly FCF

-$1.55 M
-$2.37 M-290.79%

September 30, 2024

Summary

Performance

3-Month Change

-290.79%

1-Year Change

-114.48%

3-Year Change

+93.17%

5-Year Change

-113.72%

NEO Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.65%
NEO quarterly free cash flow is higher than 65.65% of companies in Healthcare sector

High & Low

All-time High

$12.23 M
NEO quarterly free cash flow is currently -112.69% below its historical high of $12.23 million

3-Year Low

-$37.26 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
NEO next earnings announcement is scheduled for Feb 18, 2025

OtherNEOcash flowmetrics:

Quarterly CFO

$9.25 M
NEO quarterly cash flow from operations is $9.25 million

Quarterly CFF

$1.18 M
NEO quarterly cash flow from financing activities is $1.18 million

Quarterly CFI

-$3.52 M
NEO quarterly cash flow from investing activities is -$3.52 million

Quarterly CAPEX

$10.80 M
NEO quarterly capital expenditures is $10.80 million

TTM FCF

-$21.51 M
+$8.22 M+27.64%

September 30, 2024

Summary

Performance

3-Month Change

+27.64%

1-Year Change

+29.94%

3-Year Change

+66.71%

5-Year Change

-744.07%

NEO TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.59%
NEO TTM free cash flow is higher than 46.59% of companies in Healthcare sector

High & Low

All-time High

$30.48 M
NEO TTM free cash flow is currently -170.59% below its historical high of $30.48 million

3-Year Low

-$120.43 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
NEO next earnings announcement is scheduled for Feb 18, 2025

OtherNEOcash flowmetrics:

TTM CFO

$15.01 M
NEO TTM cash flow from operations is $15.01 million

TTM CFF

$5.23 M
NEO TTM cash flow from financing activities is $5.23 million

TTM CFI

$35.52 M
NEO TTM cash flow from investing activities is $35.52 million

TTM CAPEX

$36.52 M
NEO TTM capital expenditures is $36.52 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$30.70 M
NEO annual free cash flow is -$30.70 million

Annual CFO

-$1.95 M
NEO annual cash flow from operations is -$1.95 million

Annual CAPEX

$28.75 M
NEO annual capital expenditures is $28.75 million

NEO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+68.3%-114.5%+29.9%
3 y3 years-11.1%+93.2%+66.7%
5 y5 years-200.8%-113.7%-744.1%

NEO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+68.3%-114.5%+95.8%at high+82.1%
5 y5-year-1019.3%+68.3%-114.5%+95.8%-744.1%+82.1%
alltimeall time-200.8%+68.3%-112.7%+95.8%-170.6%+82.1%

NeoGenomics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.55 M(-290.8%)
-$21.51 M(-27.6%)
Jun 2024
-
$814.00 K(-102.6%)
-$29.73 M(-24.9%)
Mar 2024
-
-$31.50 M(-393.7%)
-$39.59 M(+28.9%)
Dec 2023
-$30.70 M(-68.3%)
$10.73 M(-209.8%)
-$30.70 M(-38.2%)
Sep 2023
-
-$9.77 M(+8.1%)
-$49.65 M(-22.4%)
Jun 2023
-
-$9.04 M(-60.0%)
-$64.00 M(-22.2%)
Mar 2023
-
-$22.62 M(+175.2%)
-$82.24 M(-15.1%)
Dec 2022
-$96.88 M(+6.6%)
-$8.22 M(-65.9%)
-$96.88 M(-19.6%)
Sep 2022
-
-$24.12 M(-11.6%)
-$120.43 M(+1.2%)
Jun 2022
-
-$27.29 M(-26.8%)
-$119.06 M(+4.0%)
Mar 2022
-
-$37.26 M(+17.3%)
-$114.50 M(+26.0%)
Dec 2021
-$90.86 M(+228.8%)
-$31.76 M(+39.7%)
-$90.86 M(+40.6%)
Sep 2021
-
-$22.74 M(+0.0%)
-$64.62 M(+31.3%)
Jun 2021
-
-$22.74 M(+66.9%)
-$49.21 M(+66.2%)
Mar 2021
-
-$13.62 M(+146.8%)
-$29.62 M(+7.2%)
Dec 2020
-$27.64 M(-927.4%)
-$5.52 M(-24.7%)
-$27.64 M(+11.3%)
Sep 2020
-
-$7.33 M(+133.2%)
-$24.83 M(+301.6%)
Jun 2020
-
-$3.14 M(-73.0%)
-$6.18 M(-44.8%)
Mar 2020
-
-$11.64 M(+328.5%)
-$11.20 M(-435.4%)
Dec 2019
$3.34 M(-89.0%)
-$2.72 M(-124.0%)
$3.34 M(-81.7%)
Sep 2019
-
$11.32 M(-238.7%)
$18.29 M(+38.5%)
Jun 2019
-
-$8.16 M(-381.4%)
$13.21 M(-44.4%)
Mar 2019
-
$2.90 M(-76.3%)
$23.73 M(-22.1%)
Dec 2018
$30.48 M(+601.1%)
$12.23 M(+96.3%)
$30.48 M(+48.8%)
Sep 2018
-
$6.23 M(+163.8%)
$20.48 M(+5.7%)
Jun 2018
-
$2.36 M(-75.5%)
$19.38 M(+3.7%)
Mar 2018
-
$9.65 M(+331.4%)
$18.69 M(+329.9%)
Dec 2017
$4.35 M(-68.8%)
$2.24 M(-56.4%)
$4.35 M(-1386.1%)
Sep 2017
-
$5.13 M(+207.2%)
-$338.00 K(-115.0%)
Jun 2017
-
$1.67 M(-135.6%)
$2.25 M(-29.5%)
Mar 2017
-
-$4.69 M(+91.6%)
$3.19 M(-77.1%)
Dec 2016
$13.94 M(+233.7%)
-$2.45 M(-131.7%)
$13.94 M(-22.5%)
Sep 2016
-
$7.72 M(+195.6%)
$17.98 M(+48.2%)
Jun 2016
-
$2.61 M(-56.9%)
$12.13 M(+2.2%)
Mar 2016
-
$6.06 M(+281.5%)
$11.87 M(+184.0%)
Dec 2015
$4.18 M(-26.4%)
$1.59 M(-15.2%)
$4.18 M(+65.6%)
Sep 2015
-
$1.87 M(-20.2%)
$2.52 M(-17.6%)
Jun 2015
-
$2.35 M(-244.0%)
$3.06 M(-21.6%)
Mar 2015
-
-$1.63 M(+2331.3%)
$3.91 M(-31.2%)
Dec 2014
$5.68 M(+2528.7%)
-$67.00 K(-102.8%)
$5.68 M(+20.4%)
Sep 2014
-
$2.41 M(-24.4%)
$4.71 M(+30.1%)
Jun 2014
-
$3.19 M(+2146.5%)
$3.62 M(+88.0%)
Mar 2014
-
$142.00 K(-113.8%)
$1.93 M(+792.1%)
Dec 2013
$216.00 K(-105.2%)
-$1.03 M(-178.0%)
$216.00 K(-75.9%)
Sep 2013
-
$1.32 M(-11.6%)
$895.00 K(-141.0%)
Jun 2013
-
$1.49 M(-195.2%)
-$2.19 M(-34.5%)
Mar 2013
-
-$1.57 M(+347.0%)
-$3.33 M(-19.5%)
Dec 2012
-$4.14 M
-$351.00 K(-80.0%)
-$4.14 M(+33.1%)
Sep 2012
-
-$1.76 M(-609.9%)
-$3.11 M(+85.0%)
Jun 2012
-
$345.00 K(-114.5%)
-$1.68 M(+5.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$2.38 M(-449.9%)
-$1.59 M(+92.3%)
Dec 2011
-$828.00 K(-72.1%)
$680.00 K(-306.7%)
-$828.00 K(-33.8%)
Sep 2011
-
-$329.00 K(-175.5%)
-$1.25 M(-42.1%)
Jun 2011
-
$436.00 K(-127.0%)
-$2.16 M(-25.7%)
Mar 2011
-
-$1.61 M(-726.0%)
-$2.90 M(-2.1%)
Dec 2010
-$2.97 M(+20.5%)
$258.00 K(-120.8%)
-$2.97 M(-29.5%)
Sep 2010
-
-$1.24 M(+299.4%)
-$4.21 M(+11.4%)
Jun 2010
-
-$310.00 K(-81.5%)
-$3.78 M(-0.7%)
Mar 2010
-
-$1.68 M(+70.2%)
-$3.81 M(+54.4%)
Dec 2009
-$2.46 M(+284.9%)
-$986.00 K(+22.3%)
-$2.46 M(+57.3%)
Sep 2009
-
-$806.00 K(+140.6%)
-$1.57 M(+152.7%)
Jun 2009
-
-$335.00 K(-0.6%)
-$619.70 K(-46.0%)
Mar 2009
-
-$337.00 K(+282.1%)
-$1.15 M(+79.1%)
Dec 2008
-$640.10 K(-79.7%)
-$88.20 K(-162.8%)
-$640.10 K(-42.6%)
Sep 2008
-
$140.50 K(-116.3%)
-$1.11 M(-45.9%)
Jun 2008
-
-$861.90 K(-608.5%)
-$2.06 M(-20.2%)
Mar 2008
-
$169.50 K(-130.1%)
-$2.58 M(-18.2%)
Dec 2007
-$3.16 M(+189.2%)
-$562.80 K(-30.2%)
-$3.16 M(+1.4%)
Sep 2007
-
-$806.80 K(-41.6%)
-$3.12 M(+30.5%)
Jun 2007
-
-$1.38 M(+240.2%)
-$2.39 M(+110.4%)
Mar 2007
-
-$406.40 K(-21.8%)
-$1.13 M(+3.8%)
Dec 2006
-$1.09 M(+7.1%)
-$519.50 K(+560.9%)
-$1.09 M(+32.4%)
Sep 2006
-
-$78.60 K(-39.5%)
-$825.40 K(-10.8%)
Jun 2006
-
-$129.90 K(-64.4%)
-$925.10 K(-18.1%)
Mar 2006
-
-$364.50 K(+44.4%)
-$1.13 M(+10.8%)
Dec 2005
-$1.02 M(+37.0%)
-$252.40 K(+41.6%)
-$1.02 M(+3.0%)
Sep 2005
-
-$178.30 K(-46.8%)
-$989.60 K(-1.5%)
Jun 2005
-
-$335.00 K(+31.9%)
-$1.00 M(+17.4%)
Mar 2005
-
-$253.90 K(+14.2%)
-$855.70 K(+15.0%)
Dec 2004
-$744.10 K(+24.9%)
-$222.40 K(+14.8%)
-$744.20 K(+7.6%)
Sep 2004
-
-$193.70 K(+4.3%)
-$691.50 K(+16.8%)
Jun 2004
-
-$185.70 K(+30.4%)
-$591.90 K(-2.6%)
Mar 2004
-
-$142.40 K(-16.1%)
-$607.70 K(+2.0%)
Dec 2003
-$595.60 K(-25.8%)
-$169.70 K(+80.3%)
-$595.60 K(-0.7%)
Sep 2003
-
-$94.10 K(-53.3%)
-$599.50 K(-18.7%)
Jun 2003
-
-$201.50 K(+54.6%)
-$737.60 K(-1.8%)
Mar 2003
-
-$130.30 K(-24.9%)
-$751.30 K(-6.4%)
Dec 2002
-$802.80 K(+899.8%)
-$173.60 K(-25.2%)
-$802.80 K(+13.2%)
Sep 2002
-
-$232.20 K(+7.9%)
-$708.90 K(+61.4%)
Jun 2002
-
-$215.20 K(+18.4%)
-$439.30 K(+80.7%)
Mar 2002
-
-$181.80 K(+128.1%)
-$243.10 K(+214.5%)
Dec 2001
-$80.30 K(-54.7%)
-$79.70 K(-313.1%)
-$77.30 K(+80.6%)
Sep 2001
-
$37.40 K(-296.8%)
-$42.80 K(-66.1%)
Jun 2001
-
-$19.00 K(+18.8%)
-$126.10 K(+17.9%)
Mar 2001
-
-$16.00 K(-64.6%)
-$107.00 K(-39.6%)
Dec 2000
-$177.10 K
-$45.20 K(-1.5%)
-$177.10 K(+34.3%)
Sep 2000
-
-$45.90 K(<-9900.0%)
-$131.90 K(+53.4%)
Jun 2000
-
$100.00(-100.1%)
-$86.00 K(-0.1%)
Mar 2000
-
-$86.10 K(+258.8%)
-$86.10 K(+258.8%)
Mar 1999
-
-$24.00 K
-$24.00 K

FAQ

  • What is NeoGenomics annual free cash flow?
  • What is the all time high annual FCF for NeoGenomics?
  • What is NeoGenomics annual FCF year-on-year change?
  • What is NeoGenomics quarterly free cash flow?
  • What is the all time high quarterly FCF for NeoGenomics?
  • What is NeoGenomics quarterly FCF year-on-year change?
  • What is NeoGenomics TTM free cash flow?
  • What is the all time high TTM FCF for NeoGenomics?
  • What is NeoGenomics TTM FCF year-on-year change?

What is NeoGenomics annual free cash flow?

The current annual FCF of NEO is -$30.70 M

What is the all time high annual FCF for NeoGenomics?

NeoGenomics all-time high annual free cash flow is $30.48 M

What is NeoGenomics annual FCF year-on-year change?

Over the past year, NEO annual free cash flow has changed by +$66.18 M (+68.31%)

What is NeoGenomics quarterly free cash flow?

The current quarterly FCF of NEO is -$1.55 M

What is the all time high quarterly FCF for NeoGenomics?

NeoGenomics all-time high quarterly free cash flow is $12.23 M

What is NeoGenomics quarterly FCF year-on-year change?

Over the past year, NEO quarterly free cash flow has changed by -$12.28 M (-114.48%)

What is NeoGenomics TTM free cash flow?

The current TTM FCF of NEO is -$21.51 M

What is the all time high TTM FCF for NeoGenomics?

NeoGenomics all-time high TTM free cash flow is $30.48 M

What is NeoGenomics TTM FCF year-on-year change?

Over the past year, NEO TTM free cash flow has changed by +$9.19 M (+29.94%)